Lilly and China's NCCD announce collaboration to advance scientific understanding and care for people living with diabetes and cardiovascular disease

Collaboration between China's National Center for Cardiovascular Diseases and Lilly aims to improve care for people living with Type 2 diabetes in China The Lilly and NCCD collaboration will address four strategic areas to advance scientific understandi... Biopharmaceuticals, Cardiology, Endocrinology Eli Lilly, diabetes, cardiovascular disease, diabetic kidney disease
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news